From a Molecule to a Drug: Chemical Features Enhancing Pharmacological Potential

This book collects contributions published in the Special Issue “From a Molecule to a Drug: Chemical Features Enhancing Pharmacological Potential” and dealing with successful stories of drug improvement or design using classic protocols, quantum mechanical mechanistic investigation, or hybrid approa...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (234 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05195nam-a2201309z--4500
001 993553550304498
005 20231214133650.0
006 m o d
007 cr|mn|---annan
008 202208s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5600000000483077 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/91184 
035 |a (EXLCZ)995600000000483077 
041 0 |a eng 
100 1 |a Ribaudo, Giovanni  |4 edt 
245 1 0 |a From a Molecule to a Drug: Chemical Features Enhancing Pharmacological Potential 
246 |a From a Molecule to a Drug 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (234 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a This book collects contributions published in the Special Issue “From a Molecule to a Drug: Chemical Features Enhancing Pharmacological Potential” and dealing with successful stories of drug improvement or design using classic protocols, quantum mechanical mechanistic investigation, or hybrid approaches such as QM/MM or QM/ML (machine learning). In the last two decades, computer-aided modeling has strongly supported scientists’ intuition to design functional molecules. High-throughput screening protocols, mainly based on classical mechanics’ atomistic potentials, are largely employed in biology and medicinal chemistry studies with the aim of simulating drug-likeness and bioactivity in terms of efficient binding to the target receptors. The advantages of this approach are quick outcomes, the possibility of repurposing commercially available drugs, consolidated protocols, and the availability of large databases. On the other hand, these studies do not intrinsically provide reactivity information, which requires quantum mechanical methodologies that are only applicable to significantly smaller and simplified systems at present. These latter studies focus on the drug itself, considering the chemical properties related to its structural features and motifs. Overall, such simulations provide necessary insights for a better understanding of the chemistry principles that rule the diseases at the molecular level, as well as possible mechanisms for restoring the physiological equilibrium. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Pharmacology  |2 bicssc 
653 |a SARS-CoV-2 
653 |a benzoic acid derivatives 
653 |a gallic acid 
653 |a molecular docking 
653 |a reactivity parameters 
653 |a selenoxide elimination 
653 |a one-pot 
653 |a imine-enamine 
653 |a reaction mechanism 
653 |a DFT calculations 
653 |a selenium 
653 |a anti-inflammatory drugs 
653 |a QSAR 
653 |a pain management 
653 |a cyclooxygenase 
653 |a multitarget drug 
653 |a cannabinoid 
653 |a neuropathic pain 
653 |a clopidogrel 
653 |a NMR study 
653 |a oxone 
653 |a peroxymonosulfate 
653 |a sodium halide 
653 |a thienopyridine 
653 |a drug discovery 
653 |a precision medicine 
653 |a pharmacodynamics 
653 |a pharmacokinetics 
653 |a coronavirus SARS-CoV-2 
653 |a COVID-19 
653 |a 3-chymotrypsin-like protease 
653 |a pyrimidonic pharmaceuticals 
653 |a molecular dynamics simulations 
653 |a binding free energy 
653 |a β-carrageenan 
653 |a antioxidant activity 
653 |a Box-Behken 
653 |a extraction 
653 |a Eucheuma gelatinae 
653 |a physic-chemistry 
653 |a rheology 
653 |a quercetin 
653 |a quercetin 3-O-glucuronide 
653 |a cisplatin 
653 |a nephrotoxicity 
653 |a cytoprotection 
653 |a lithium therapy 
653 |a neurocytology 
653 |a toxicology 
653 |a neuroprotection 
653 |a chemoinformatics 
653 |a big data 
653 |a methadone hydrochloride 
653 |a pharmaceutical solutions 
653 |a drug compounding 
653 |a high performance liquid chromatography 
653 |a stability study 
653 |a microbiology 
653 |a fucoidan 
653 |a alginate 
653 |a L-selectin 
653 |a E-selectin 
653 |a MCP-1 
653 |a ICAM-1 
653 |a THP-1 macrophage 
653 |a monocyte migration 
653 |a protein binding 
653 |a breast milk 
653 |a M/P ratio 
653 |a statistical modeling 
653 |a molecular descriptors 
653 |a chromatographic descriptors 
653 |a affinity chromatography 
653 |a anti-ACE 
653 |a anti-DPP-IV 
653 |a gastrointestinal digestion 
653 |a in silico 
653 |a molecular dynamics 
653 |a paramyosin 
653 |a seafood 
653 |a target fishing 
776 |z 3-0365-4753-3 
776 |z 3-0365-4754-1 
700 1 |a Orian, Laura  |4 edt 
700 1 |a Ribaudo, Giovanni  |4 oth 
700 1 |a Orian, Laura  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 06:01:52 Europe/Vienna  |f system  |c marc21  |a 2022-08-13 21:17:26 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5339474900004498&Force_direct=true  |Z 5339474900004498  |b Available  |8 5339474900004498